Similar articles for PMID: 30355544

Year	Number of Results
1991	2
1992	1
1994	1
1995	1
1997	2
1998	6
1999	4
2000	5
2002	4
2003	1
2005	1
2006	7
2007	3
2008	6
2009	5
2010	9
2011	7
2012	13
2013	9
2014	5
2015	6
2016	6
2017	2
2018	5
2019	3
2020	4
2021	3
2022	2
2024	0

1

Pegylated interferon-α2b for local control of Langerhans cell sarcoma.

Ishitsuka Y, Iwamoto K, Oya K, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M. Ishitsuka Y, et al. Eur J Dermatol. 2018 Dec 1;28(6):835-836. doi: 10.1684/ejd.2018.3411. Eur J Dermatol. 2018. PMID: 30355544 No abstract available.

2

A case of malignant melanoma that developed multiple metastases after switching from interferon-beta to pegylated interferon-alpha-2b as adjuvant therapy.

Fukumoto T, Fujiwara S, Sakaguchi M, Oka M, Nishigori C. Fukumoto T, et al. Eur J Dermatol. 2018 Feb 1;28(1):115-116. doi: 10.1684/ejd.2017.3169. Eur J Dermatol. 2018. PMID: 29171409 No abstract available.

3

An update on pegylated IFN-α2b for the adjuvant treatment of melanoma.

Agarwala SS. Agarwala SS. Expert Rev Anticancer Ther. 2012 Nov;12(11):1449-59. doi: 10.1586/era.12.120. Expert Rev Anticancer Ther. 2012. PMID: 23249109 Review.

4

Narcoleptic-like Episodes in a Patient Receiving Pegylated Interferon-alpha 2b: A Case Report and Review of Literature.

Lawson BO, Khong HT. Lawson BO, et al. Anticancer Res. 2017 Mar;37(3):1365-1368. doi: 10.21873/anticanres.11456. Anticancer Res. 2017. PMID: 28314304 Review.

5

A case of an adult Langerhans cell sarcoma.

Ma X, Li W, Du J, Cai L, Zhang J. Ma X, et al. Int J Dermatol. 2016 Jan;55(1):92-6. doi: 10.1111/ijd.12440. Epub 2014 Oct 14. Int J Dermatol. 2016. PMID: 25312302 No abstract available.

6

Effective control of rush progression of CD8+ mycosis fungoides with pegylated interferon.

Fujimura T, Okuyama R, Hashimoto A, Watanabe H, Nakagawa S, Tagami H, Aiba S. Fujimura T, et al. Acta Derm Venereol. 2006;86(2):161-2. doi: 10.2340/00015555-0017. Acta Derm Venereol. 2006. PMID: 16648924 Free article. No abstract available.

7

Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen.

Uchida K, Kobayashi S, Inukai T, Noriki S, Imamura Y, Nakajima H, Yayama T, Orwotho N, Baba H. Uchida K, et al. J Orthop Sci. 2008 Jan;13(1):89-93. doi: 10.1007/s00776-007-1184-4. Epub 2008 Feb 16. J Orthop Sci. 2008. PMID: 18274862 No abstract available.

8

Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?

Quintás-Cardama A, Verstovsek S. Quintás-Cardama A, et al. Leuk Lymphoma. 2007 Mar;48(3):445-6. doi: 10.1080/10428190701217087. Leuk Lymphoma. 2007. PMID: 17454579 No abstract available.

9

Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study.

Grob JJ, Jouary T, Dréno B, Asselineau J, Gutzmer R, Hauschild A, Leccia MT, Landthaler M, Garbe C, Sassolas B, Herbst RA, Guillot B, Chene G, Pehamberger H. Grob JJ, et al. Eur J Cancer. 2013 Jan;49(1):166-74. doi: 10.1016/j.ejca.2012.07.018. Epub 2012 Sep 10. Eur J Cancer. 2013. PMID: 22975216 Clinical Trial.

10

Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis.

Messori A, Fadda V, Maratea D, Trippoli S, Marinai C. Messori A, et al. Eur J Gastroenterol Hepatol. 2014 Feb;26(2):246-8. doi: 10.1097/MEG.0b013e3283657e20. Eur J Gastroenterol Hepatol. 2014. PMID: 24366456 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year